Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Timeline For Health Legislation Slips As HELP, Finance Committees Hit Snags
Senators delayed work Wednesday on one health care reform bill and hit partisan roadblocks on another as key lawmakers insisted they are still on track to have a bill on the floor by the middle of summer, The Washington Post reports.

Phase III Study Showed Lucentis Improved Vision In Patients With Branch Retinal Vein Occlusion
Genentech, Inc. announced today that the Phase III study BRAVO showed Lucentis® (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in patients with macular edema due to branch retinal vein occlusion. The safety profile of Lucentis was consistent with previous experience and no new adverse events related to Lucentis were observed in the study. Retinal vein occlusion (RVO) is a common cause of vision loss that occurs when blood flow through a retinal vein becomes blocked, such as by a blood clot.
News of the day
Health Unit Reports Three Cases Of E. Coli O157:H7 In London
Over the last five days, the Middlesex-London Health Unit has received reports of three children with E. coli O157:H7. To receive three laboratory confirmed cases of E. coli O157:H7 in such a short timeframe is unusual. In two of these cases, the common food consumed was kofta (spiced ground beef) purchased on June 14 and 15 from the Westmount Halal Food Store located at 490 Wonderland Road South. The of the third child"s infection is currently unknown. This child"s family also eats halal food but did not purchase any food from the Westmount Halal Food Store.
Medical Devices

Pharmacies Urged To Register From 1 - 31 July 2009 To Receive Early-bird Payment

Community pharmacies are urged to register to participate in Phase 2 of the Dose Administration Aids (DAA) and Patient Medication Profile (PMP) programs. Pharmacies registering from 1 to 31 July 2009 will be eligible for the full incentive payment of $2,250 for DAA and $1,250 for PMP (+GST). While registrations will still be accepted after July, a lesser incentive payment will apply. "We need as many pharmacies as possible to participate in Phase 2 of these programs to ensure the ongoing and sustainable delivery of these important services," said Mr Kos Sclavos, .National President of the Pharmacy Guild of Australia. In response to feedback from community pharmacy, the DAA and PMP programs, managed by the Pharmacy Guild of Australia, have been reviewed and revamped to make participation in them easier and systems more user-friendly. The amount of time and data required has been reduced, and the payment deadlines have been simplified. "DAA and PMP services offer clear benefits to patients and the wider community. Patients have better medication management, and better continuity of care. The community have fewer hospitalizations associated with medicine misadventure and delayed admissions to aged care services," said Mr Warwick Plunkett, National President of the Pharmaceutical Society of Australia. Medication misadventure is estimated to cost the health sector $380 million a year ( "Improving Medication Safety" by the Australian Council for Safety and Quality in Healthcare, 2002). The DAA program allows pharmacist to organise patients" medicines into weekly blister packs. The PMP allows pharmacists to produce a comprehensive profile of the patient"s medicines, including information about instructions for use, appearance and generic substitution availability. The DAA and PMP Programs are funded under the Better Community Health Initiative of the Fourth Community Pharmacy Agreement by the Australian Government Department of Health and Ageing. In mid-June, all pharmacies will receive a new Pharmacy Readiness Kit with information and new PMP promotional materials to support their participation. For more information visit the Guild website at http://www.guild.org.au Pharmaceutical Society of Australia


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009